Dopamine neuronal loss contributes to memory and reward dysfunction in a model of Alzheimer’s disease

Cited by (521)

Items 501–521 of 521

1. Exploring and Targeting the Connection of Iron and Copper Homeostasis to Neurodegenerative Diseases
   Xin Liu, Lin Jia, Kerong Wu, Mo Chen, Ji-Chao Sun, Chuanbin Yang, Cheng-Chao Xu, Jie Sun, Ji-Gang Wang, Lingyun Dai · 2026 · MedComm
2. The relationship between personality traits and Alzheimer’s disease: a narrative review
   A. Bednorz, Dorota Religa · 2026 · Frontiers in Neurology
3. Patterns of Typical and Atypical Age-related Brainstem Volume losses
   Susanne Mueller, R. Scott Mackin · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
4. Screen-Printed Electrochemical Sensors on Textile for Dopamine Sensing
   Saima Qureshi, Akhil Chandran Mukkattu Kuniyil, Lazar Milić · 2026
5. Ventral striatal neuroimmune signalling biases the expression of social memory in male mice
   Marco Rinaudo, Sara Autelitano, Chiara D’Amelio, I.Nifo Sarrapochiello, Giulia Puliatti, G. Boni, R. Sollazzo, Domenica Donatella Li Puma, F. Paciello, Francesca Natale et al. · 2026 · Brain Behavior and Immunity
6. mTOR drives cerebrovascular dysfunction and blood-brain barrier breakdown in a model of Alzheimer’s disease with cerebral amyloid angiopathy
   Candice E. Van Skike, Lauren R. Miller, Stephen F. Hernandez, Stacy A. Hussong, Haneen Makhlouf, Aishwarya Muppala, Nicholas DeRosa, Jordan B. Jahrling, Kelly T. Dineley, Verónica Galván · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
7. Prenatal immune activation and adult Poly(I:C) re-challenge promote neuroimmune priming and AD-related behavioural, cellular and molecular alterations in wild-type mice
   Giacomo Giacovazzo, Valentina Latina, Zuleyha Nihan Yurtsever, Iliana Piccolino, Filomena Iannuzzi, Paola Bossù, Giuseppina Amadoro, Roberto Coccurello · 2026 · Frontiers in Immunology
8. Midbrain dopamine loss drives parvalbumin interneuron vulnerability through tissue plasminogen activator-linked perineuronal-net breakdown and hippocampal disinhibition
   Emma Cauzzi, Serena Ficchì, Maria Luisa De Paolis, Luana Saba, Martina Montanari, Gilda Loffredo, Livia La Barbera, Paraskevi Krashia, Annalisa Nobili, Marcello D’Amelio · 2026 · Neurobiology of Disease
9. Intranasal dopamine: Anatomical pathways, biological mechanisms and neuromodulatory potential
   Owen Yuan-Hsin Chao, Susanne Nikolaus, Claudia Mattern, Lih‐Chu Chiou, Joseph P. Huston · 2026 · Neuroscience & Biobehavioral Reviews
10. Dopamine D3 receptor blockade restores hippocampal synaptic plasticity and rescues memory deficits in Alzheimer's disease mouse models
    Maria Rosaria Tropea, Giuseppe Aceto, Roberta Carmela Trovato, Emanuele Nicitra, Nicole Santuccio, Giorgia Intili, Marcello D’Ascenzo, Daniela Puzzo · 2026 · Frontiers in Aging Neuroscience
11. Serotonergic System Dysregulation in Alzheimer’s Disease
    Nour F. Al-Ghraiybah, Amer E. Alkhalifa, Dylan Spivey, Thomas Averill, Blake Engelkemier, Patricia Haro Lopez, Mary Grace Stuckey, Luke Jenkins, Amal Kaddoumi · 2026 · ACS Chemical Neuroscience
12. Selective impairment of long-term depression in accumbal D1R+ MSNs involves calcium-permeable AMPARs in early Alzheimer's disease
    Nicolás Riffo-Lepe, Juliana González-Sanmiguel, Isaias Meza, Paulina Saavedra, Lorena Armijo‐Weingart, Helena Zambrano, Ailín Riquelme, Armando G. Salinas, Loreto San Martín, Luis Gerardo Aguayo · 2026 · Neurobiology of Disease
13. A fully integrated non-invasive flexible biosensor based on vertically grown gold nanowire forests for continuous wireless monitoring of dopamine
    Qingwen Zhang, Wenjing Zhou, Qihao Li · 2026 · Biosensors and Bioelectronics
14. Neuroinflammatory and molecular pathways in Alzheimer’s disease: mechanistic crosstalk and emerging therapeutic opportunities
    Abhay Thakur, Rohit R. Sharma, Sneha Kumari, Dev Prakash, A Sanjana Devi · 2026 · Inflammopharmacology
15. Hierarchical inference dysfunction in autism and Alzheimer's disease: A conceptual predictive-coding framework from hyper-precision to predictive collapse
    Roberto Coccurello · 2026 · European Journal of Pharmacology
16. Environmental Pollutant Formaldehyde Exposure Contributes to a Decrease in Real-Time Dopamine Concentration Dynamics in the Brain Reward Circuitry and Immunomodulating Gut Microbiome
    Peibo Xu, Mei Shen · 2026 · ACS Chemical Neuroscience
17. Convergent vulnerability and divergent outcomes of the dopaminergic system in Parkinson’s and Alzheimer’s diseases
    Yu-Ting Xi, Chen-xi Jia, H Q Wang, P. Liu, Peng Li, Qianqian Niu, Yaling Yin · 2026 · Ageing Research Reviews
18. APOE4-dependent cholinergic/dopaminergic contributions to clinical symptoms across Alzheimer’s disease spectrum: A retrospective observational study
    Sungwoo Kang, Seun Jeon, Donggeon Lee, Hanbi Lee, Su-Hee Jeon, Minsun Choi, Young‐gun Lee, Na-Young Shin, Mijin Yun, Byoung Seok Ye · 2026 · European Journal of Nuclear Medicine and Molecular Imaging
19. Combinatorial mechanisms specify cellular location and neurotransmitter identity during planarian neurogenesis
    Kendall B. Clay, Taylor Medlock-Lanier, R. N. GRIMES, Olabamibo O. Oke, Brice T. Hudson, Macey M. Wilson, Nikolay M. Filipov, Rachel H. Roberts-Galbraith · 2026 · Nature Communications
20. The Interplay of Metabolic Dysfunction, Neuroinflammation, and Mitochondrial Dysfunction in Balance Impairment: Insights from Type 2 Diabetes Mellitus and Alzheimer’s Disease
    Sodiq Fakorede, Olubodun Michael Lateef, Augustine Lishilinimye Udefa, Abayomi Oyeyemi Ajagbe͓, Sharmistha Roy, Priscilla Onaopemipo Akosile, Taiwo Ayomide Awobona, Godson Emeka Anyanwu · 2026 · Molecular Neurobiology
21. Evaluation of Anthranilamide Derivatives on Learning and Memory Processes in Naïve Rats: In Silico Predictions and In Vivo Behavioral Profiling
    Miglena Milusheva, Darinka Slavcheva Dimitrova, K. Saracheva, Vera Gledacheva, Iliyana D. Stefanova, Stoyanka Nikolova · 2026 · Sci